Products for Research Use Only
RegisterLogin

Vudalimab

CAT: 0804-HY-P99166-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99166-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Vudalimab is a potent dual PD-1 and CTLA-4 inhibitor as a fully humanized bispecific monoclonal antibody. Vudalimab targets immune checkpoint receptors PD-1 and CTLA-4 and promotes tumor-selective T-cell activation[1].
CAS Number
2329669-72-7
UNSPSC
12352203
Target
CTLA-4; PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cancer
Assay Protocol
https://www.medchemexpress.com/vudalimab.html
Purity
99.0
Solubility
10 mM in DMSO
Smiles
[Vudalimab]
Molecular Weight
(144.5 kDa)
References & Citations
[1]Hedvat M, et, al. Dual Blockade of PD1 and CTLA4 with Bispecific Antibody XmAb20717 Promotes Human T Cell Activation and Proliferation.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
MBS5818654Vudalimab
GTR18337549-01Vudalimab Antibody
E55B1269Vudalimab (Reference antibody)
DHH02222Research Grade Vudalimab
ICH5113-25mgVudalimab Biosimilar - Research Grade
ABS-326-100ugVudalimab Biosimilar, Research Grade
21-990Vudalimab - Research Grade Biosimilar
GTR18697394-01Vudalimab Human Monoclonal Antibody
C00929Vudalimab (Anti-CTLA4 & PD-1)

Popular Products